D. Ma

P. Macdonald, C. Hayward, A. Keogh, 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase

P. Browett, A. Schwarer, I. Gathmann, 2003, Leukemia.

Hematopoietic stem cell transplant recipients surviving at least 2 years from transplant have survival rates approaching population levels in the modern era of transplantation.

I. Kerridge, J. Szer, D. Ma, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.

J. Simpson, J. Szer, D. Ma, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma.

N. Schmitz, G. Salles, J. Radford, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue.

D. Campana, D. Mason, G. Janossy, 1985, Journal of immunology.

A population-based analysis of the effect of autologous hematopoietic cell transplant in the treatment of multiple myeloma

J. Simpson, J. Szer, D. Ma, 2013, Leukemia & lymphoma.

Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study.

A. López-Guillermo, F. Bosch, A. Nagler, 2019, The Lancet. Haematology.

Endothelial progenitor cells, angioblasts, and angiogenesis--old terms reconsidered from a current perspective.

J. Kovacic, R. Graham, D. Ma, 2008, Trends in cardiovascular medicine.

Cell therapy for disc degeneration--potentials and pitfalls.

H. Brisby, D. Ma, A. Diwan, 2004, The Orthopedic clinics of North America.

Chromosomal analysis of bone marrow stromal fibroblasts in allogeneic HLA compatible sibling bone marrow transplantations.

D. Ma, J. Biggs, S. Purvis-Smith, 1987, Leukemia research.

Successful lymphoablative autologous haematopoietic stem cell transplantation in three cases of severe autoimmune disease despite reduced dose cyclophosphamide conditioning—do we need 200 mg/kg cyclophosphamide?

D. Ma, J. Moore, A. Carr, 2022, Bone Marrow Transplantation.

Autologous Hematopoietic Stem Cell Transplant for Systemic Sclerosis Improves Anemia from Gastric Antral Vascular Ectasia

M. Danta, D. Ma, J. Sahhar, 2015, Journal of Rheumatology.

Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia.

D. Ma, P. Galettis, J. Boutagy, 1994, British Journal of Cancer.

Decreased ecto-5'nucleotidase activity of peripheral blood lymphocytes in human monoclonal gammopathies: correlation with tumor cell kinetics.

U. Dianzani, M. Boccadoro, A. Pileri, 1985, Blood.

Autopsy Findings in Bone Marrow Transplantation

D. Ma, J. Biggs, D. Moir, 1982, Pathology.

Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia

Andrew K. Brown, Sarah L. Field, P. Emery, 2004, Arthritis research & therapy.

Randomized intergroup trial of first line treatment for patients <=60 years with diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) with a CHOP-like regimen with or without the anti-CD20 antibody rituximab -early stopping after the first interim analysis.

M. Pfreundschuh, M. Loeffler, P. Zinzani, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

5'nucleotidase, adenosine deaminase and purine nucleoside phosphorylase activities in acute leukaemia.

M. Greaves, H. Prentice, A. Hoffbrand, 1982, Leukemia research.

BCR-ABL Levels Continue To Decrease up to 42 Months after Commencement of Standard Dose Imatinib in Patients with Newly Diagnosed Chronic Phase CML Who Achieve a Major Molecular Response.

P. Browett, A. Schwarer, Z. Rudzki, 2004 .

Rituximab ( Anti-CD 20 Monoclonal Antibody ) for the Treatment of Patients With Relapsing or Refractory Aggressive Lymphoma : A Multicenter Phase II Study

V. Diehl, B. Coiffier, J. Radford, 1998 .

A technique for rapid isolation of bone marrow mononuclear cells using Ficoll‐Metrizoate and the IBM 2991 blood cell processor

G. Janossy, H. Prentice, A. Hoffbrand, 1982, British journal of haematology.

Haemopoietic reconstitution after allogeneic bone marrow transplantation in man: recovery of haemopoietic progenitors (CFU‐Mix, BFU‐E and CFU‐GM)

D. Ma, J. Biggs, D. Varga, 1987, British journal of haematology.

A Ph+ acute myeloid leukaemia expressing both CML-type and ALL-type BCR/ABL mRNA transcripts.

D. Ma, J. Yin, B. G. Williams, 1994, Leukemia & lymphoma.

Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and New Zealand: older recipients receiving myeloablative conditioning at increased mortality risk.

J. Simpson, J. Szer, D. Ma, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Poor prognosis in patients with steroid refractory acute graft versus host disease treated with etanercept: a multi-centre analysis

J. Sierra, R. Martino, D. Ma, 2018, Bone Marrow Transplantation.

Non‐malignant bone marrow necrosis: A report of two cases

D. Ma, A. Concannon, J. Moore, 1998, Pathology.

The role of purine metabolic enzymes and terminal deoxynucleotidyl transferase in intrathymic T-cell differentiation.

G. Janossy, A. Hoffbrand, D. Ma, 1983, Immunology today.

Effect of thymosin and phorbol ester on purine metabolic enzymes and cell surface phenotype in a malignant T-cell line (MOLT-3).

A. Hoffbrand, D. Ma, G. Price, 1983, Leukemia research.

Interferon response in chronic myeloid leukaemia correlates with ABL/BCR expression: a preliminary study

D. Ma, C. Arthur, J. Yin, 1995, British journal of haematology.

Enzymes of purine metabolism in human peripheral lymphocyte subpopulations.

G. Janossy, A. Hoffbrand, D. Ma, 1982, Clinical and experimental immunology.

The fate of transplanted xenogeneic bone marrow‐derived stem cells in rat intervertebral discs

H. Brisby, Sylvia A. Chung, D. Ma, 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Biochemical and immunological differentiation of human thymocytes induced by thymic hormones.

A. Hoffbrand, D. Ma, G. Price, 1983, Immunology.

Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.

N. Schmitz, C. Gisselbrecht, N. Mounier, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Direct Comparison of Four Hematopoietic Differentiation Methods from Human Induced Pluripotent Stem Cells

E. Wolvetang, D. Ma, T. Molloy, 2020, Stem cell reports.

Distribution of terminal deoxynucleotidyl transferase and purine degradative and synthetic enzymes in subpopulations of human thymocytes.

G. Janossy, A. Hoffbrand, D. Ma, 1982, Journal of immunology.

Acute life‐threatening cardiovascular toxicity with umbilical cord blood infusion: The role of dextran

D. Ma, K. Fay, J. Kwan, 2010, American journal of hematology.

Specificity and sensitivity of immunocytochemistry for detecting P-glycoprotein in haematological malignancies.

J. Gala, D. Ma, D. Bell, 1994, Journal of clinical pathology.

Long-term culture of autologous transplanted bone marrow for acute myeloid leukaemia: evidence for an in vitro haemopoietic defect and lack of correlation with the speed of engraftment.

V. Deneys, P. Herman, D. Ma, 1995, Bone marrow transplantation.

Mobilization of predominantly Philadelphia chromosome‐negative blood progenitors using cyclophosphamide and rHUG‐CSF in early chronic‐phase chronic myeloid leukaemia: correlation with Sokal prognostic index and haematological control

R. Herrmann, J. Szer, A. Schwarer, 1997, British journal of haematology.

Frontiers in Pluripotent Stem Cells Research and Therapeutic Potentials Bench-To-Bedside

Ying S Hu, P. Sachdev, T. Das, 2012 .

Nucleotide metabolism and enzyme inhibitors in thymic acute lymphoblastic leukaemia.

A. Hoffbrand, D. Ma, H. G. Prentice, 1983, Haematology and blood transfusion.

Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study

N. Schmitz, J. Radford, C. Gisselbrecht, 2017, Bone Marrow Transplantation.

Outcome of patients with relapsed diffuse large B-cell lymphoma who fail second-line salvage regimens in the International CORAL study

N. Schmitz, G. Salles, J. Radford, 2016, Bone Marrow Transplantation.

A study of serum free medium culture on the cloning efficiency of human bone marrow myeloid and erythroid progenitors

D. Ma, L. Dowton, G. Georgiou, 1990, Pathology.

DNA strand breakage and ADP-ribosyl transferase mediated DNA ligation during stimulation of human bone marrow cells by granulocyte-macrophage colony stimulating activity.

A. Ho, A. Hoffbrand, D. Ma, 1984, Leukemia research.

Differentiation of rodent bone marrow mesenchymal stem cells into intervertebral disc-like cells following coculture with rat disc tissue.

H. Brisby, Sylvia A. Chung, D. Ma, 2009, Tissue engineering. Part A.

Mitoxantrone in relapsed and refractory acute leukemia.

D. Ma, A. Ho, H. G. Prentice, 1984, Seminars in oncology.

Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.

R. Herrmann, J. Szer, A. Schwarer, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION: REMOVAL OF RED BLOOD CELLS FROM DONOR MARROW AVOIDING RECIPIENT ANTIBODY DEPLETION

H. Prentice, A. Hoffbrand, D. Ma, 1982, The Lancet.

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant

D. Ma, I. Sutton, J. Moore, 2018, Front. Immunol..

Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR

L. To, A. Trickett, D. Ma, 2003, Leukemia.

Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)

M. Sormani, J. D. de Vries-Bouwstra, B. Sharrack, 2019, Bone Marrow Transplantation.

Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis

R. Zivadinov, J. Zaunders, M. Barnett, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

Factors influencing myeloid stem cell (CFU-C) survival after cryopreservation of human marrow and chronic granulocytic leukemia cells.

D. Ma, J. Biggs, L. Johnson, 1982, Cryobiology.

Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998–2006: factors associated with improved survival outcome

P. Ganly, J. Simpson, J. Szer, 2011, Leukemia & lymphoma.

DETECTION OF A MULTIDRUG RESISTANT PHENOTYPE IN ACUTE NON-LYMPHOBLASTIC LEUKAEMIA

J. Isbister, D. Ma, D. Bell, 1987, The Lancet.

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.

V. Diehl, B. Coiffier, J. Radford, 1998, Blood.

Mesenchymal Stem Cell-Based Therapies for Parkinson’s Disease: Progress, Controversies and Lessons for the Future

D. Ma, Melissa L. M. Khoo, Helen Tao, 2011 .

Induction of muscle-regenerative multipotent stem cells from human adipocytes by PDGF-AB and 5-azacytidine

W. Walsh, L. Hesson, E. Hardeman, 2020, Science Advances.

BMP-2 enhances TGF-beta3-mediated chondrogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in alginate bead culture.

D. Ma, A. Diwan, B. Shen, 2009, Tissue engineering. Part A.

Studies of hemopoietic stromal fibroblastic colonies in patients undergoing bone marrow transplantation.

D. Ma, J. Biggs, W. Da, 1986, Experimental hematology.

Comparison of two methods for concentrating stem cells for cryopreservation and transplantation

D. Ma, J. Biggs, 1982, Transfusion.

Donor marrow progenitors (CFU-Mix, BFU-E and CFU-GM) and haemopoietic engraftment following HLA matched sibling bone marrow transplantation.

D. Ma, J. Biggs, D. Varga, 1987, Leukemia research.

AUTOLOGOUS BONE MARROW TRANSPLANT IN THE TREATMENT OF MALIGNANT DISEASE

D. Ma, J. Biggs, 1981, The Medical journal of Australia.

Increased activity and improved outcome in unrelated donor haemopoietic cell transplants for acute myeloid leukaemia in Australia, 1992–2005

J. Szer, D. Ma, J. Moore, 2011, Internal medicine journal.

THE REQUIREMENT OF THYMIC IRRADIATION FOR INDUCTION OF MIXED CHIMERISM AND RENAL ALLOGRAFT TOLERANCE IN NON-HUMAN PRIMATES

R. Colvin, T. Kawai, D. Ma, 2020 .

Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004.

J. Simpson, J. Szer, D. Ma, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

I. Kerridge, D. Ma, W. Stevenson, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft Transit Time Has No Effect on Outcome of Unrelated Donor Hematopoietic Cell Transplants Performed in Australia and New Zealand: A Study from the Australasian Bone Marrow Transplant Recipient Registry.

J. Szer, D. Ma, H. Blacklock, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bone–Marrow Transplantation: A Preliminary Study in Aplasia and Leukaemia

D. Ma, J. Biggs, Transplant Team, 1980, The Medical journal of Australia.

A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013.

J. Szer, D. Ma, A. Dodds, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A SYBR green‐based real‐time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients

Yi-Mo Deng, D. Ma, J. Moore, 2006, European journal of haematology.

A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis.

P. Brooks, J. Snowden, G. McColl, 2002, Arthritis and rheumatism.

Maintenance with rituximab after autologous stem cell transplantation in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL): CORAL final analysis.

N. Schmitz, C. Gisselbrecht, M. Bargetzi, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Notch Signalling Inhibits CD4 Expression during Initiation and Differentiation of Human T Cell Lineage

D. Ma, J. Moore, S. Carlin, 2012, PloS one.